Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2431105
Max Phase: Preclinical
Molecular Formula: C39H52ClN5O6
Molecular Weight: 685.87
Molecule Type: Small molecule
Associated Items:
ID: ALA2431105
Max Phase: Preclinical
Molecular Formula: C39H52ClN5O6
Molecular Weight: 685.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cccc(OC)c1-c1cc(C(=O)NC2(C(=O)O)C3CC4CC(C3)CC2C4)nn1-c1ccc(C(=O)N(C)CCCN(C)C)cc1C(C)C.Cl
Standard InChI: InChI=1S/C39H51N5O6.ClH/c1-23(2)29-21-26(37(46)43(5)15-9-14-42(3)4)12-13-31(29)44-32(35-33(49-6)10-8-11-34(35)50-7)22-30(41-44)36(45)40-39(38(47)48)27-17-24-16-25(19-27)20-28(39)18-24;/h8,10-13,21-25,27-28H,9,14-20H2,1-7H3,(H,40,45)(H,47,48);1H
Standard InChI Key: CUYNEHGBVHUQQW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 685.87 | Molecular Weight (Monoisotopic): 685.3839 | AlogP: 5.71 | #Rotatable Bonds: 13 |
Polar Surface Area: 126.23 | Molecular Species: ZWITTERION | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.94 | CX Basic pKa: 9.30 | CX LogP: 2.54 | CX LogD: 2.54 |
Aromatic Rings: 3 | Heavy Atoms: 50 | QED Weighted: 0.23 | Np Likeness Score: -0.63 |
1. Peddibhotla S, Hedrick MP, Hershberger P, Maloney PR, Li Y, Milewski M, Gosalia P, Gray W, Mehta A, Sugarman E, Hood B, Suyama E, Nguyen K, Heynen-Genel S, Vasile S, Salaniwal S, Stonich D, Su Y, Mangravita-Novo A, Vicchiarelli M, Roth GP, Smith LH, Chung TD, Hanson GR, Thomas JB, Caron MG, Barak LS, Pinkerton AB.. (2013) Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor., 4 (9): [PMID:24611085] [10.1021/ml400176n] |
2. Hershberger PM, Hedrick MP, Peddibhotla S, Mangravita-Novo A, Gosalia P, Li Y, Gray W, Vicchiarelli M, Smith LH, Chung TD, Thomas JB, Caron MG, Pinkerton AB, Barak LS, Roth GP.. (2014) Imidazole-derived agonists for the neurotensin 1 receptor., 24 (1): [PMID:24332089] [10.1016/j.bmcl.2013.11.026] |
Source(1):